## Abstract ## Purpose: To compare the diagnostic accuracy of contrast‐enhanced computed tomography (CE‐CT), contrast‐enhanced ultrasonography (CE‐US), superparamagnetic iron oxide‐enhanced magnetic resonance imaging (SPIO‐MRI), and gadoxetic acid‐enhanced MRI (Gd‐EOB‐MRI) in the evaluation of col
Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles
✍ Scribed by Assaf A. Gilad; Hanneke W.M. van Laarhoven; Michael T. McMahon; Piotr Walczak; Arend Heerschap; Michal Neeman; Peter C.M. van Zijl; Jeff W.M. Bulte
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 643 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A major challenge for cellular and molecular MRI is to study interactions between two different cell populations or biological processes. We studied the possibility to simultaneously image contrast agents based on two different MRI contrast mechanisms: chemical exchange saturation transfer (CEST) and enhancement of T2 relaxation. Various amounts of superparamagnetic iron oxide (SPIO) nanoparticles were mixed with a fixed concentration (250 μM) of the CEST agent poly‐L‐lysine. T2 maps, CEST maps, and frequency‐dependent saturation spectra were then measured. Color‐coded overlay maps demonstrated the feasibility of concurrent dual contrast enhancement. We found that at concentrations lower than 5 μg(Fe)/mL both contrast agents can be imaged simultaneously. At higher concentrations, the iron‐based agent can be used to “shut off” the signal arising from the CEST agent. These initial findings are a first step toward using dual CEST/T2 contrast imaging for studying multiple cellular or molecular targets simultaneously in vivo. Magn Reson Med, 2009. © 2009 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract The aim of the study was to compare the first‐passage profiles of dysprosium diethylenetriamine penta‐acetic acid bis(methylamide) (DTPA BMA) and the superparamagnetic iron oxide particles NSR 0430 in regions with severe and moderate cerebral ischemia. In seven rats subjected to middle